dermatan sulfate has been researched along with ARSB Deficiency in 19 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (21.05) | 18.7374 |
1990's | 4 (21.05) | 18.2507 |
2000's | 5 (26.32) | 29.6817 |
2010's | 3 (15.79) | 24.3611 |
2020's | 3 (15.79) | 2.80 |
Authors | Studies |
---|---|
Bhattacharyya, S; Tobacman, JK | 1 |
Bocart, S; Bouchot, A; Bournique, B; Broqua, P; Entchev, E; Jantzen, I; Junien, JL; Lacombe, O; Luccarini, JM; Masson, P; Tallandier, M | 1 |
Golda, A; Lalik, A; Pacholczyk, M; Poterala-Hejmo, A; Student, S; Tylki-Szymańska, A | 1 |
Fukao, T; Giugliani, R; Khan, SA; Kobayashi, H; Mason, RW; Orii, K; Orii, T; Suzuki, Y; Tomatsu, S; Yamaguchi, S | 1 |
Millington, DS; Wood, T; Young, SP; Zhang, H | 1 |
Bigger, BW; Church, HJ; Mercer, J; O'Meara, A; Thornley, M; Tylee, K; Wraith, JE; Wynn, RF | 1 |
An, Y; Auray-Blais, C; Bhérer, P; Clarke, JT; Gagnon, R; Millington, DS; Young, SP; Zhang, HH | 1 |
Amedeo, S; Castagnaro, M; De Maria, R; Divari, S; Macrì, B; Marino, F; Mazzullo, G; Trusso, A | 1 |
Tobacman, JK | 1 |
Bhattacharyya, S; Danziger, RS; Kotlo, K; Shukla, S; Tobacman, JK | 1 |
Klein, U; von Figura, K | 1 |
Desnick, RJ; Haskins, ME; McGovern, MM; Schuchman, EH; Vine, DT | 1 |
Crawley, AC; Hopwood, JJ; Muller, VJ; Yogalingam, G | 1 |
Kondo, N; Orii, T; Sukegawa, K; Tomatsu, S | 1 |
Brumfield, LK; Byers, S; Hopwood, JJ; Ranieri, E; Rozaklis, T | 1 |
Haskins, ME; Schuchman, EH; Simonaro, CM | 1 |
Donnelly, PV; Gniot-Szulzycka, J | 1 |
Gregersen, HN; Güttler, F; Tønnesen, T | 1 |
Cantz, M; O'Brien, JF; Spranger, J | 1 |
3 review(s) available for dermatan sulfate and ARSB Deficiency
Article | Year |
---|---|
Profound Impact of Decline in N-Acetylgalactosamine-4-Sulfatase (Arylsulfatase B) on Molecular Pathophysiology and Human Diseases.
Topics: Chondroitin Sulfates; Dermatan Sulfate; Humans; Mucopolysaccharidosis VI; N-Acetylgalactosamine-4-Sulfatase; Sulfates | 2022 |
Does deficiency of arylsulfatase B have a role in cystic fibrosis?
Topics: Bacterial Infections; Chondroitin Sulfates; Cystic Fibrosis; Dermatan Sulfate; Glycosaminoglycans; Humans; Ion Exchange; Lung; Mucopolysaccharidosis VI; N-Acetylgalactosamine-4-Sulfatase; Pseudomonas Infections; Sodium; Sulfates; Tuberculosis | 2003 |
[Mucopolysaccharidosis type VI (Maroteaux-Lamy syndrome)].
Topics: Biomarkers; Chondro-4-Sulfatase; Dermatan Sulfate; Diagnosis, Differential; Humans; Mucopolysaccharidosis VI; Mutation; Prognosis | 1998 |
1 trial(s) available for dermatan sulfate and ARSB Deficiency
Article | Year |
---|---|
Improved metabolic correction in patients with lysosomal storage disease treated with hematopoietic stem cell transplant compared with enzyme replacement therapy.
Topics: Biomarkers; Chondroitin Sulfates; Dermatan Sulfate; Enzyme Therapy; Enzymes; Hematopoietic Stem Cell Transplantation; Humans; Mucopolysaccharidosis I; Mucopolysaccharidosis II; Mucopolysaccharidosis VI | 2009 |
15 other study(ies) available for dermatan sulfate and ARSB Deficiency
Article | Year |
---|---|
Odiparcil, a potential glycosaminoglycans clearance therapy in mucopolysaccharidosis VI-Evidence from in vitro and in vivo models.
Topics: Administration, Oral; Animals; Cattle; Cells, Cultured; Chondroitin Sulfates; Dermatan Sulfate; Disease Models, Animal; Endothelial Cells; Female; Glycosaminoglycans; Glycosides; Humans; In Vitro Techniques; Male; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Mucopolysaccharidosis VI; Rats; Rats, Sprague-Dawley | 2020 |
A Possible Role for Arylsulfatase G in Dermatan Sulfate Metabolism.
Topics: Amino Acid Sequence; Arylsulfatases; Catalytic Domain; Dermatan Sulfate; Endothelial Cells; Gene Silencing; Humans; Models, Molecular; Mucopolysaccharidosis VI; Myocytes, Smooth Muscle; N-Acetylgalactosamine-4-Sulfatase; Organ Specificity; Protein Binding; Protein Conformation; Pulmonary Artery; RNA, Messenger; Sequence Alignment; Sequence Homology, Amino Acid; Tissue Array Analysis; Up-Regulation | 2020 |
Glycosaminoglycans analysis in blood and urine of patients with mucopolysaccharidosis.
Topics: Adolescent; Adult; Biomarkers; Child; Child, Preschool; Dermatan Sulfate; Female; Glycosaminoglycans; Heparitin Sulfate; Humans; Keratan Sulfate; Male; Mucopolysaccharidoses; Mucopolysaccharidosis II; Mucopolysaccharidosis III; Mucopolysaccharidosis IV; Mucopolysaccharidosis VI; Tandem Mass Spectrometry; Young Adult | 2018 |
A straightforward, quantitative ultra-performance liquid chromatography-tandem mass spectrometric method for heparan sulfate, dermatan sulfate and chondroitin sulfate in urine: an improved clinical screening test for the mucopolysaccharidoses.
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Chondroitin Sulfates; Chromatography, Liquid; Dermatan Sulfate; Glycosaminoglycans; Heparitin Sulfate; Humans; Infant; Middle Aged; Mucopolysaccharidoses; Mucopolysaccharidosis II; Mucopolysaccharidosis III; Mucopolysaccharidosis IV; Mucopolysaccharidosis VI; Radioisotope Dilution Technique; Reference Values; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; Young Adult | 2015 |
Efficient analysis of urinary glycosaminoglycans by LC-MS/MS in mucopolysaccharidoses type I, II and VI.
Topics: Adolescent; Adult; Biomarkers; Case-Control Studies; Child; Child, Preschool; Chromatography, Liquid; Creatinine; Dermatan Sulfate; Enzyme Replacement Therapy; Female; Glycosaminoglycans; Heparitin Sulfate; Humans; Infant; Male; Mucopolysaccharidosis I; Mucopolysaccharidosis II; Mucopolysaccharidosis VI; Reference Values; Tandem Mass Spectrometry; Young Adult | 2011 |
Mucopolysaccharidosis VI in a Siamese/short-haired European cat.
Topics: Animals; Breeding; Cat Diseases; Cats; Dermatan Sulfate; Diagnosis, Differential; Male; Mucopolysaccharidosis VI; N-Acetylgalactosamine-4-Sulfatase; Radiography | 2002 |
Distinct effects of N-acetylgalactosamine-4-sulfatase and galactose-6-sulfatase expression on chondroitin sulfates.
Topics: Antibodies; Cell Line, Tumor; Chondroitin ABC Lyase; Chondroitin Sulfates; Chondroitinsulfatases; Decorin; Dermatan Sulfate; Extracellular Matrix Proteins; Female; Gene Expression Regulation, Enzymologic; Gene Silencing; Heparin; Heparitin Sulfate; Humans; Mucopolysaccharidosis VI; N-Acetylgalactosamine-4-Sulfatase; Proteoglycans; RNA, Small Interfering; Syndecan-1 | 2008 |
Characterization of dermatan sulfate in mucopolysaccharidosis VI. Evidence for the absence of hyaluronidase-like enzymes in human skin fibroblasts.
Topics: Cells, Cultured; Chondroitin; Dermatan Sulfate; Fibroblasts; Glycosaminoglycans; Humans; Hyaluronoglucosaminidase; Molecular Weight; Mucopolysaccharidoses; Mucopolysaccharidosis VI; Skin | 1980 |
Enhancement of residual arylsulfatase B activity in feline mucopolysaccharidosis VI by thiol-induced subunit association.
Topics: Animals; Cats; Chondro-4-Sulfatase; Chromatography, Gel; Cysteamine; Dermatan Sulfate; Dithiothreitol; Leukocytes; Molecular Weight; Mucopolysaccharidoses; Mucopolysaccharidosis VI; Sulfatases; Sulfhydryl Compounds | 1982 |
Two mutations within a feline mucopolysaccharidosis type VI colony cause three different clinical phenotypes.
Topics: Animals; Arthrography; beta-N-Acetylhexosaminidases; Cats; Chondro-4-Sulfatase; Dermatan Sulfate; Disease Models, Animal; Female; Genotype; Humans; Joints; Leukocytes; Male; Mucopolysaccharidosis VI; Mutation; Pedigree; Phenotype | 1998 |
Glycosaminoglycan accumulation and excretion in the mucopolysaccharidoses: characterization and basis of a diagnostic test for MPS.
Topics: Animal Diseases; Animals; Cats; Dermatan Sulfate; Electrophoresis, Polyacrylamide Gel; Glycosaminoglycans; Humans; Mucopolysaccharidoses; Mucopolysaccharidosis VI | 1998 |
Articular chondrocytes from animals with a dermatan sulfate storage disease undergo a high rate of apoptosis and release nitric oxide and inflammatory cytokines: a possible mechanism underlying degenerative joint disease in the mucopolysaccharidoses.
Topics: Animals; Apoptosis; Bone Matrix; Cartilage, Articular; Cats; Chondrocytes; Coculture Techniques; Cytokines; Dermatan Sulfate; Inflammation Mediators; Joint Diseases; Lipopolysaccharides; Mucopolysaccharidosis VI; Nitric Oxide; Rats; Tumor Necrosis Factor-alpha | 2001 |
Arylsulphatase B (Maroteaux-Lamy factor): a part of the enzyme system responsible for sulphate release from mucopolysaccharide fragment.
Topics: Chondro-4-Sulfatase; Dermatan Sulfate; Glycosaminoglycans; Mucopolysaccharidoses; Mucopolysaccharidosis VI; Oligosaccharides; Sulfatases | 1976 |
Normal MPS excretion, but dermatan sulphaturia, combined with a mild Maroteaux-Lamy phenotype.
Topics: Adult; Cells, Cultured; Cetylpyridinium; Chondro-4-Sulfatase; Dermatan Sulfate; Diagnostic Errors; Fibroblasts; Glycosaminoglycans; Hip Dislocation; Humans; Kyphosis; Lysosomes; Male; Mucopolysaccharidosis IV; Mucopolysaccharidosis VI; Phenotype; Uronic Acids | 1991 |
Proceedings: The defect in Maroteaux-Lamy disease (mucopolysaccharidosis VI, subtype A): deficiency of N-acetylgalactosamine-4-sulfatase.
Topics: Acetylgalactosamine; Dermatan Sulfate; Humans; Mucopolysaccharidoses; Mucopolysaccharidosis VI; Sulfatases | 1974 |